What amazes me is how quickly awareness changed from ignorance and hatred to adoration and unbridled bullishness.
Less than three months ago, the list of Bitcoin haters included Wall Street heavyweights like JP Morgan’s CEO Jamie Dimon, emerging-markets guru Mark Mobius and Nobel-winning author Robert Shiller.
Fast-forward to today, though, and leading Wall Streeters are now embracing cryptocurrencies whole hog.
Just last week, hedge fund legend Michael Novogratz told CNBC that Bitcoin could “easily” top $40,000 in 2018.
Now Bitcoin has topped $11,000 — up more than 1,300% in 2017.
And according to Google Trends data , Bitcoin has surpassed the bombastic president of the United States when it comes to web searches.
So I don’t blame you for reflexively believing that we’re in bubble territory.
But fight the response!
Cryptocurrencies are still just babes.
The combined market cap of all digital currencies is a mere $300 billion. That compares with U.S. stocks at $20 trillion.
In other words, there’s plenty more demand to be awakened as the crypto craze continues.
That move could begin in earnest on Dec. 18, thanks to a pivotal decision by key market participants that “has the potential to add legitimacy and thus increase the appeal of the cryptocurrency market to both retail and institutional investors,” according to Nikolaos Panigirtzoglou, a global markets strategist at JP Morgan.
The countdown is on!
Monsanto was recently in the headlines again because a key ingredient in its Roundup weed killer, glyphosate, is now officially “known to cause cancer.” Here are a few other perverse inventions the company has engineered. Read more » 
Driverless cars are the ultimate disrupter. Heck, Ford executives now make regular trips to Silicon Valley to meet with startups a millionth Ford’s size. But I was recently asked if driverless cars are any different than the Segway. Let’s review… Read more » 
Thanks to scientific advances in genetic sequencing, deep neural networks and DNA editing technologies, a legit “Brain Boom” is upon us. Nothing races higher than a biotechnology stock with a hot new discovery. Here are a few more such stocks to consider when placing your brain bets. Read more » 
A consortium of 116 industry insiders decided to sign a loose agreement — one that bans the use of lethal autonomous weapons (or “killer robots”). Imagine a world where gunpowder was never allowed to be developed. Or a world where nuclear fission was deemed too dangerous. Are such mandates a good idea? Or do they thwart the natural progress of innovation — and, most importantly, investment opportunities? Read more »